Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Genetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population.

Xu J, Yin Z, Gao W, Liu L, Yin Y, Liu P, Shu Y.

PLoS One. 2013 Oct 11;8(10):e77024. doi: 10.1371/journal.pone.0077024. eCollection 2013.

2.

Association of miR-502-binding site single nucleotide polymorphism in the 3'-untranslated region of SET8 and TP53 codon 72 polymorphism with non-small cell lung cancer in Chinese population.

Yang S, Guo H, Wei B, Zhu S, Cai Y, Jiang P, Tang J.

Acta Biochim Biophys Sin (Shanghai). 2014 Feb;46(2):149-54. doi: 10.1093/abbs/gmt138. Epub 2013 Dec 26.

PMID:
24374662
3.

Prognostic value of microRNA 502 binding site SNP in the 3'-untranslated region of the SET8 gene in patients with non-Hodgkin's lymphoma.

Diao L, Su H, Wei G, Li T, Gao Y, Zhao G, Guo Z.

Tumori. 2014 Sep-Oct;100(5):553-8. doi: 10.1700/1660.18180.

4.

A polymorphism at the miR-502 binding site in the 3'-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome.

Guo Z, Wu C, Wang X, Wang C, Zhang R, Shan B.

Int J Cancer. 2012 Sep 15;131(6):1318-22. doi: 10.1002/ijc.27352. Epub 2012 Jan 11.

5.

A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer.

Lee SY, Choi JE, Jeon HS, Hong MJ, Choi YY, Kang HG, Yoo SS, Lee EB, Jeong JY, Lee WK, Lee J, Cha SI, Kim CH, Kim YT, Jheon S, Son JW, Park JY.

Ann Oncol. 2015 Jun;26(6):1142-8. doi: 10.1093/annonc/mdv100. Epub 2015 Feb 24.

PMID:
25716425
6.

[Polymorphism at the miR-502 binding site in the 3' untranslated region of SET8 gene is associated with the risk of clear cell renal cell carcinoma].

Xu JS, Bai YL, Zhang JX, Cui LW, Zhang HR, Zhang SL.

Zhonghua Zhong Liu Za Zhi. 2016 Jun 23;38(6):476-80. doi: 10.3760/cma.j.issn.0253-3766.2016.06.014. Chinese.

PMID:
27346408
7.

A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population.

Xu J, Yin Z, Shen H, Gao W, Qian Y, Pei D, Liu L, Shu Y.

PLoS One. 2013 Nov 6;8(11):e79135. doi: 10.1371/journal.pone.0079135. eCollection 2013.

9.

Genetic variation in BCL2 3'-UTR was associated with lung cancer risk and prognosis in male Chinese population.

Xu P, Liu L, Wang J, Zhang K, Hong X, Deng Q, Xiang J, Zhang X, He M, Wu T, Guo H.

PLoS One. 2013 Aug 16;8(8):e72197. doi: 10.1371/journal.pone.0072197. eCollection 2013.

10.

MicroRNA-binding site SNPs in deregulated genes are associated with clinical outcome of non-small cell lung cancer.

Xu J, Tian S, Yin Z, Wu S, Liu L, Qian Y, Pei D, Gao W, Xu J, Yin Y, Liu P, Shu Y.

Lung Cancer. 2014 Sep;85(3):442-8. doi: 10.1016/j.lungcan.2014.06.010. Epub 2014 Jun 21.

PMID:
24997136
11.

An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset.

Song F, Zheng H, Liu B, Wei S, Dai H, Zhang L, Calin GA, Hao X, Wei Q, Zhang W, Chen K.

Clin Cancer Res. 2009 Oct 1;15(19):6292-300. doi: 10.1158/1078-0432.CCR-09-0826. Epub 2009 Sep 29.

12.

MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients.

Yang J, Lan H, Huang X, Liu B, Tong Y.

PLoS One. 2012;7(8):e42978. doi: 10.1371/journal.pone.0042978. Epub 2012 Aug 10.

13.

Polymorphism (rs16917496) at the miR-502 Binding Site of the Lysine Methyltransferase 5A (SET8) and Its Correlation with Colorectal Cancer in Iranians.

Mosallayi M, Simonian M, Khosravi S, Salehi AR, Khodadoostan M, Sebghatollahi V, Baradaran A, Salehi R.

Adv Biomed Res. 2017 Jul 14;6:77. doi: 10.4103/2277-9175.210656. eCollection 2017.

14.

A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the risk of epithelial ovarian cancer.

Wang C, Guo Z, Wu C, Li Y, Kang S.

Cancer Genet. 2012 Jul-Aug;205(7-8):373-6. doi: 10.1016/j.cancergen.2012.04.010.

PMID:
22867998
15.

Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.

Yoda S, Soejima K, Hamamoto J, Yasuda H, Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Naoki K, Betsuyaku T.

Lung Cancer. 2014 Sep;85(3):366-72. doi: 10.1016/j.lungcan.2014.06.009. Epub 2014 Jun 21.

PMID:
25001509
16.

[SNP rs16917496 within SET8 3'UTR is associated with the age of onset of breast cancer].

Zhang BL, Song FJ, Zheng H, Zhang LN, Zhao YR, Chen KX.

Zhonghua Zhong Liu Za Zhi. 2012 Nov;34(11):835-7. doi: 10.3760/cma.j.issn.0253-3766.2012.11.008. Chinese.

PMID:
23291132
17.

A functional polymorphism at microRNA-629-binding site in the 3'-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population.

Yang L, Li Y, Cheng M, Huang D, Zheng J, Liu B, Ling X, Li Q, Zhang X, Ji W, Zhou Y, Lu J.

Carcinogenesis. 2012 Feb;33(2):338-47. doi: 10.1093/carcin/bgr272. Epub 2011 Nov 22.

PMID:
22114071
18.

Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.

Hong MJ, Choi YY, Jang JA, Jung HJ, Lee SY, Lee WK, Yoo SS, Lee J, Cha SI, Kim CH, Lee E, Jeon HS, Son JW, Park JY.

J Thorac Oncol. 2013 Jun;8(6):703-10. doi: 10.1097/JTO.0b013e318288dc0a.

19.

BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification.

Jiang BY, Zhang XC, Su J, Meng W, Yang XN, Yang JJ, Zhou Q, Chen ZY, Chen ZH, Xie Z, Chen SL, Wu YL.

Mol Cancer. 2013 Jun 12;12:61. doi: 10.1186/1476-4598-12-61.

20.

Supplemental Content

Support Center